NorthCrest Asset Manangement’s Dr. Reddy's Laboratories RDY Stock Holding History

NorthCrest Asset Manangement’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$488K	Sell	35,100 -375	-1%	-$5.06K	0.01%	568
2026 Q1	$473K	Sell	35,475 -17,250	-33%	-$240K	0.01%	499
2025 Q4	$729K	Sell	52,725 -1,050	-2%	-$14.7K	0.02%	440
2025 Q3	$754K	Sell	53,775 -750	-1%	-$10.8K	0.02%	390
2025 Q2	$822K	Sell	54,525 -500	-0.9%	-$7.14K	0.02%	337
2025 Q1	$726K	Hold	55,025	–	–	0.02%	357
2024 Q4	$869K	Sell	55,025 -450	-0.8%	-$6.76K	0.03%	316
2024 Q3	$881K	Sell	55,475 -500	-0.9%	-$8.05K	0.03%	309
2024 Q2	$853K	Hold	55,975	–	–	0.03%	295
2024 Q1	$821K	Buy	55,975 +1,550	+3%	+$22.6K	0.03%	295
2023 Q4	$757K	Sell	54,425 -350	-0.6%	-$4.68K	0.03%	302
2023 Q3	$733K	Sell	54,775 -1,700	-3%	-$23K	0.03%	290
2023 Q2	$713K	Sell	56,475 -975	-2%	-$11.4K	0.03%	303
2023 Q1	$654K	Hold	57,450	–	–	0.03%	314
2022 Q4	$595K	Hold	57,450	–	–	0.03%	249
2022 Q3	$601K	Hold	57,450	–	–	0.03%	274
2022 Q2	$636K	Hold	57,450	–	–	0.03%	275
2022 Q1	$640K	Sell	57,450 -150	-0.3%	-$1.7K	0.03%	260
2021 Q4	$754K	Buy	+57,600	New	+$726K	0.04%	260

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

NorthCrest Asset Manangement's RDY Position: Q2 2026 in Review

NorthCrest Asset Manangement reduced its Dr. Reddy's Laboratories (RDY) stake by 1.1% in Q2 2026, selling an estimated $5.06K and leaving 35,100 shares worth $488K. The position accounts for 0.01% of the portfolio, ranked #568.

NorthCrest Asset Manangement first reported a position in RDY in Q4 2021 and has held it in 19 quarters since. The position peaked at $881K in Q3 2024. 101 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

NorthCrest Asset Manangement held 35,100 shares of Dr. Reddy's Laboratories worth $488K as of Q2 2026.
NorthCrest Asset Manangement sold 375 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $5.06K.
Dr. Reddy's Laboratories made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #568 holding.
NorthCrest Asset Manangement first reported a position in Dr. Reddy's Laboratories in Q4 2021 and has held it in 19 quarters since.
NorthCrest Asset Manangement's Dr. Reddy's Laboratories position peaked at $881K in Q3 2024.
101 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.